CD274 and neoplasm: In mouse models of melanoma, tumor-inherent activation of WNT/β-catenin signaling pathway has been found to restrain T cells from populating the tumor and lead to T-cell exclusion, which in turn results in the primary resistance against PD-L1/CTLA-4 treatment (58).